![]() |
產(chǎn)地 | 進(jìn)口、國產(chǎn) |
品牌 | 上海莼試 |
保存條件 | Store at -20 °C |
貨號 | CS11268 |
應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 |
CAS編號 | |
抗體名 | Anti-SCUBE3 |
克隆性 | |
靶點 | 詳見說明書 |
適應(yīng)物種 | 詳見說明書 |
形態(tài) | 詳見說明書 |
宿主 | 詳見說明書 |
亞型 | IgG |
標(biāo)識物 | 詳見說明書 |
濃度 | 1mg/1ml% |
免疫原 | KLH conjugated synthetic peptide derived from Human SCUBE3 |
產(chǎn)品訂購信息:
英文名稱 Anti-SCUBE3
中文名稱 新型分泌細(xì)胞表面蛋白/成骨細(xì)胞相關(guān)蛋白SCUBE3抗體說明書
別 名 CEGF3; CUB and EGF containing protein 3; CUB and EGF-like domain-containing protein 3; CUB domain and EGF like repeat containing 3; DKFZp686B09105; DKFZp686B1223; DKFZp686D20108; FLJ34743; OTTHUMP00000016250; SCUB3_HUMAN; SCUBE 3; SCUBE3; Signal peptide; Signal peptide CUB and EGF like domain containing protein 3; Signal peptide CUB domain EGF like 3.
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Pig, Cow, Horse, Sheep
產(chǎn)品類型 一抗
研究領(lǐng)域 發(fā)育生物學(xué) 信號轉(zhuǎn)導(dǎo) 干細(xì)胞 生長因子和激素
蛋白分子量 predicted molecular weight: 107kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from Human SCUBE3
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
新型分泌細(xì)胞表面蛋白/成骨細(xì)胞相關(guān)蛋白SCUBE3抗體說明書 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
(石蠟切片需做抗原修復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 SCUBE3 is a novel secreted 993 amino acid cell-surface osteoblast protein that plays an important role in bone cell biology. While highly expressed in osteoblasts, SCUBE3 expression is unobservable or very low in non-bone tissues. SCUBE3 forms homo-oligomers and hetero-oligomers with SCUBE1, and may undergo C-terminal proteolytic cleavage or become N-glycosylated following translation. Two SCUBE3 isoforms exist as a result of alternative splicing events. SCUBE3 contains one CUB domain and nine EGF-like domains, and is encoded by a gene which maps to human chromosome 6p21.31, a region associated with a rare form of metabolic bone disease known as Paget's disease. Chromosome 6 contains 170 million base pairs and comprises nearly 6% of the human genome.
Function : Binds to TGFBR2 and activates TGFB signaling. In lungcancer cells, could serve as an endogenous autocrine and paracrineligand of TGFBR2, which could regulate TGFBR2 signaling and hencemodulate epithelial-mesenchymal transition and cancer progression.
Subunit : Forms homooligomers and heterooligomers with SCUBE1.Interacts with TGFBR2 through the CUB domain; this interaction doesnot affect TGFB1-binding to TGFBR2.
Subcellular Location : Secreted. Cell surface.
Tissue Specificity : Highly expressed in osteoblasts. Expression is low or absent in non-bone tissues.
Post-translational modifications : N-glycosylated.
May undergo proteolytic cleavage in the C-terminal region.
Similarity : Contains 1 CUB domain.
Contains 9 EGF-like domains.
Database links : UniProtKB/Swiss-Prot: Q8IX30.1
phospho-Klf5/CKLF/Kruppel like factor 5, Human, mo, rat, horse, bovine, rabbit, pig, dog 磷酸化腸道內(nèi)富含的Kruppel樣因子5抗原Multi-class antibodies規(guī)格: 0.5mg
Anti-AFP 甲胎蛋白單克隆抗體(包被)Multi-class antibodies規(guī)格: 0.1ml
Rhesus antibody Rh phospho-CASC3(Tyr181) 磷酸化易感候選基因3抗體 規(guī)格 0.1ml
豬血清封閉液 10ml Gibco原料,2%血清
VAMP-1+2+3 英文名稱: 囊泡相關(guān)膜蛋白1,2,3抗體 0.1ml
phospho-DNA PKcs (Thr2647) 英文名稱: 磷酸化DNA依賴性蛋白激酶抗體 0.1ml
Anti-AFP 甲胎蛋白單克隆抗體(包被)Multi-class antibodies規(guī)格: 0.1ml
Anti-obestatin/Ghrelin/GHRP /FITC 熒光素標(biāo)記抑制素抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Rabbit Anti-chicken IgM/HRP 辣根過氧化物酶標(biāo)記兔抗雞IgMMulti-class antibodies規(guī)格: 0.1ml
周期素依賴性激酶1抗體 Anti-CDK1 0.1ml
Goat Anti-Bovine IgG/PE-Cy3 PE-Cy3標(biāo)記的羊抗IgG 0.1ml
FAM62C 英文名稱: 延伸突觸蛋白3抗體 0.2ml
Rhesus antibody Rh PLASTIN3/T Plastin 絲束蛋白T Plastin抗體 規(guī)格 0.2ml
Rabbit Anti-chicken IgM/HRP 辣根過氧化物酶標(biāo)記兔抗雞IgMMulti-class antibodies規(guī)格: 0.1ml
SAPAP3 英文名稱: PSD95結(jié)合蛋白3抗體 0.2ml
ERC1 英文名稱: RAB6蛋白抗體 0.2ml
壞死因子-β抗體 Anti-TNF-β 0.1ml
Anti-TNF- Alpha /RBITC 紅色熒光素標(biāo)記壞死因子抗體Multi-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh Phospho-Jak3 (Tyr785) 磷酸化蛋白酪氨酸激酶JAK-3抗體 規(guī)格 0.1ml
BMPR-1A(Bone Morphogenetic protein Receptor-1A) 骨成型蛋白受體1A抗原Multi-class antibodies規(guī)格: 0.5mg
Hela, 人細(xì)胞系
NIH?3T3? 小鼠成纖維細(xì)胞
FCGR1 Others Rat 大鼠 CD64 / FCGR1A 人細(xì)胞裂解液 (陽性對照)
非洲綠猴腎細(xì)胞;BS-C-1
小梁網(wǎng)細(xì)胞Many types of cells包裝:5 × 105次方(1ml)
人小細(xì)胞細(xì)胞;NCI-H209 大鼠肺大內(nèi)皮細(xì)胞完全培養(yǎng)基 100mL
AGS人胃腺癌細(xì)胞
EPHB6 Others Mouse 小鼠 EphB6 人細(xì)胞裂解液 (陽性對照)
人臍內(nèi)皮細(xì)胞(人細(xì)胞污染);ECV-304 [ECV304;ECV 304]
犬腎細(xì)胞;MDCK(NBL-2) 腎上腺皮質(zhì)細(xì)胞,Y1細(xì)胞 RCFBF細(xì)胞,兔角膜前基質(zhì)層成纖維細(xì)胞
人胚胎;WI-38
HA Others H5N8 甲型 H5N8 (A/duck/NY/191255-59/2002) 血凝素 (Hemagglutinin / HA) 人細(xì)胞裂解液 (陽性對照)
新型分泌細(xì)胞表面蛋白/成骨細(xì)胞相關(guān)蛋白SCUBE3抗體說明書 Hela, 人細(xì)胞系
NIH?3T3? 小鼠成纖維細(xì)胞
FCGR1 Others Rat 大鼠 CD64 / FCGR1A 人細(xì)胞裂解液 (陽性對照)
非洲綠猴腎細(xì)胞;BS-C-1
小梁網(wǎng)細(xì)胞Many types of cells包裝:5 × 105次方(1ml)
人小細(xì)胞細(xì)胞;NCI-H209 大鼠肺大內(nèi)皮細(xì)胞完全培養(yǎng)基 100mL
抗體的生物素化標(biāo)記實驗要點:
1. 新型分泌細(xì)胞表面蛋白/成骨細(xì)胞相關(guān)蛋白SCUBE3抗體說明書 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析;
2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個不同的分子比來篩選最適條件;
3.用NHSB量過量也是不利的,抗原的結(jié)合位點可能因此被封閉,導(dǎo)致抗體失活;
4.由于抗體的氨基不易接近可能造成生物素化不足,此時可加入去污劑如 Triton x-100, Tween20等;
5.當(dāng)游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點時,或位于酶的催化位點時,生物素化會降低或損傷抗體蛋白的結(jié)合力或活性;
6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價結(jié)合;
7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會對生物素化抗體與親和素的結(jié)合產(chǎn)生競爭作用;
8.在細(xì)胞的熒光標(biāo)記實驗中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對某些細(xì)胞可導(dǎo)致高本底。
抗體的鑒定:
1)新型分泌細(xì)胞表面蛋白/成骨細(xì)胞相關(guān)蛋白SCUBE3抗體說明書 抗體的效價鑒定:不管是用于診斷還是用于,制備抗體的目的都是要求較高效價。不同的抗原制備的抗體,要求的效價不一。鑒定效價的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗,酶聯(lián)免疫吸附試驗等。常用的抗原所制備的抗體一般都有約成的鑒定效價的方法,以資比較。如制備抗抗體的效價,一般就采用瓊脂擴(kuò)散試驗來鑒定。
2)抗體的特異性鑒定:抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識別能力??贵w的特異性高,它的識別能力就強。衡量特異性通常以交叉反應(yīng)率來表示。交叉反應(yīng)率可用競爭抑制試驗測定。以不同濃度抗原和近似抗原分別做競爭抑制曲線,計算各自的結(jié)合率,求出各自在IC50時的濃度,并按公式計算交叉反應(yīng)率。
如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無窮大時,表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。
3)抗體親和力:是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol??贵w親和力的測定對抗體的篩選,確定抗體的用途,驗證抗體的均一性等均有重要意義。